Outcomes Analysis of Patients Receiving Local Ablative Therapy for Oligoprogressive Metastatic NSCLC Under First-Line Immunotherapy.
Huet C, Basse C, Knetki-Wroblewska M, Chilczuk P, Bonte PE, Cyrille S, Gobbini E, Du Rusquec P, Olszyna-Serementa M, Daniel C, Lucibello F, Lahmi L, Krzakowski M, Girard N.
Huet C, et al. Among authors: bonte pe.
Clin Lung Cancer. 2024 Aug 8:S1525-7304(24)00147-5. doi: 10.1016/j.cllc.2024.07.009. Online ahead of print.
Clin Lung Cancer. 2024.
PMID: 39214846